Welcome to our dedicated page for Sotera Health Co SEC filings (Ticker: SHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Sotera Health Company's SEC filings document financial results, governance matters, capital-structure activity and material events for a Nasdaq-listed healthcare services company. Form 8-K filings report operating results, Regulation FD disclosures, earnings materials, leadership succession items, board appointments, committee assignments and underwriting agreements tied to secondary sales of common stock by selling stockholders.
Proxy materials describe annual meeting proposals, director elections, advisory executive compensation votes and auditor ratification. The filings also identify SHC's common stock, par value $0.01 per share, as listed on The Nasdaq Stock Market and provide formal exhibits such as underwriting agreements, legal opinions and press releases related to reported company events.
Klee Ann R. reported acquisition or exercise transactions in this Form 4 filing.
Sotera Health Co director Ann R. Klee received an equity award in the form of restricted stock units. On May 22, 2026, she was granted 14,970 RSUs under the Sotera Health Company 2020 Omnibus Incentive Plan, with no cash paid per unit.
Each RSU represents the right to receive one share of common stock, subject to vesting. The RSUs vest in full on the earlier of the first anniversary of the grant date or immediately before the next regular annual shareholders meeting, provided she continues to serve as a non-employee director. After this grant, her reported holdings total 140,926 units and shares, consisting of 14,970 RSUs and 125,956 shares of common stock.
SHADER ALTON reported acquisition or exercise transactions in this Form 4 filing.
Sotera Health Co reported that Chief Executive Officer Alton Shader received equity awards on May 26, 2026. He was granted 203,634 shares of Common Stock as RSUs and another 375,939 RSUs, all at no cash cost, plus 101,817 performance-based share appreciation units tied to Sotera’s stock price. The RSUs and SAUs generally vest in three equal annual installments starting March 2, 2027. After these grants, he directly holds 579,573 Common shares and 101,817 SAUs.
Sotera Health Co director and Chief Executive Officer Alton Shader filed an initial Form 3 as a reporting person. This filing establishes his status as an insider but shows no reported share transactions or derivative positions, and no holdings entries are listed in the available data.
Kyle Richard G reported acquisition or exercise transactions in this Form 4 filing.
Sotera Health Co reported that director Kyle Richard G received an equity grant in the form of restricted stock units. On May 22, 2026, he was awarded 14,970 RSUs, each representing the right to receive one share of common stock if vesting conditions are met.
The RSUs will vest in full on the earlier of the first anniversary of the grant date or immediately before Sotera Health’s next regular annual shareholders meeting, provided he continues serving as a non-employee director through that date. Following this grant, he holds 14,970 shares/RSUs directly.
Krause Kenneth D. reported acquisition or exercise transactions in this Form 4 filing.
Sotera Health Co director Kenneth D. Krause received a grant of 14,970 restricted stock units (RSUs) on May 22, 2026 as equity compensation. Each RSU represents the right to receive one share of common stock, subject to vesting conditions. The RSUs vest in full on the earlier of the first anniversary of the grant date or immediately before Sotera Health’s next regular annual shareholders meeting, as long as Krause continues serving as a non-employee director. The Form 4 shows this as a non-cash award, with 14,970 shares reported as directly owned following the transaction.
CUNNINGHAM SEAN LAURENCE reported acquisition or exercise transactions in this Form 4 filing.
Sotera Health Co director Sean Laurence Cunningham received an equity award as part of his board compensation. On May 22, 2026, he was granted 14,970 restricted stock units (RSUs), each representing the right to receive one share of common stock, for no cash payment.
The RSUs vest in full on the earlier of the first anniversary of the grant date or immediately before Sotera Health’s next regular annual shareholders meeting, as long as he continues serving as a non-employee director. After this grant, Cunningham’s reported holdings total 95,751 units and shares, consisting of 14,970 RSUs and 80,781 shares of common stock.
Flynn Karen reported acquisition or exercise transactions in this Form 4 filing.
Sotera Health Co director Karen Flynn reported receiving an equity award. She was granted 14,970 restricted stock units (RSUs) on May 22, 2026 under the Sotera Health Company 2020 Omnibus Incentive Plan. After this grant, she holds a total of 54,191 equity interests, consisting of 14,970 RSUs and 39,221 shares of common stock. The RSUs vest fully on the earlier of the first anniversary of the grant date or immediately before the company’s next regular annual shareholders meeting, assuming she continues serving as a non-employee director.
Neary James reported acquisition or exercise transactions in this Form 4 filing.
Sotera Health Co director James Neary received a grant of 14,970 restricted stock units (RSUs) of Common Stock. Each RSU equals one share, vesting in full on the earlier of the first anniversary of the grant or just before the next regular annual shareholders meeting, subject to his continued service as a non-employee director. Following this award, his holdings consist of 14,970 RSUs and 80,961 shares of Common Stock, totaling 95,751 share-equivalent interests.
PETRELLA VINCENT K reported acquisition or exercise transactions in this Form 4 filing.
Sotera Health Co director Vincent K. Petrella received an equity grant of 14,970 restricted stock units (RSUs) of Common Stock on May 22, 2026. The award was made at no cash cost under the Sotera Health Company 2020 Omnibus Incentive Plan as director compensation.
Each RSU represents the right to receive one share of Common Stock, vesting in full on the earlier of the first anniversary of the grant date or immediately before the next regular annual shareholders meeting, subject to his continued service as a non-employee director. Following this grant, his position consists of 14,970 RSUs and 80,961 shares of Common Stock, for a total of 95,751 shares and RSUs.
Chen Ruoxi reported acquisition or exercise transactions in this Form 4 filing.
Sotera Health Co director Ruoxi Chen received an equity grant of 14,970 Restricted Stock Units (RSUs) on May 22, 2026. The RSUs were granted at no cash cost as part of the Sotera Health Company 2020 Omnibus Incentive Plan and represent the right to receive an equal number of common shares, subject to vesting conditions.
The RSUs will vest in full on the earlier of the first anniversary of the grant date or immediately before the next regular annual shareholders meeting, assuming Chen continues serving as a non-employee director. Following this award, Chen holds 95,751 securities in total, consisting of 14,970 RSUs and 80,961 shares of common stock.